drugset / Trial / NCT00474032

Using Botox to Treat Patients With Idiopathic Clubfoot

NCT00474032

Unknown 2000 enrolled University of British Columbia
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to determine the effectiveness of treatment of idiopathic clubfoot utilizing Botulinum Toxin Type A (Botox). This is not a hypothesis-generating study as we are reporting on outcomes of patients who have been treated by this method of clubfoot treatment.

Timeline

Start
2003-03
Primary completion
2023-03
Completion
2023-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 10 iu/kg Intramuscular

Indications